about
Cardiovascular magnetic resonance physics for clinicians: Part II.Therapeutic antibody targeting of individual Notch receptorsCardiovascular magnetic resonance physics for clinicians: part I.Modified Look-Locker inversion recovery (MOLLI) for high-resolution T1 mapping of the heart.Myocardial T1 mapping: application to patients with acute and chronic myocardial infarction.Clinical evaluation of magnetic resonance imaging in coronary heart disease: the CE-MARC study.Utilizing the activation mechanism of serine proteases to engineer hepatocyte growth factor into a Met antagonistCardiovascular magnetic resonance and single-photon emission computed tomography for diagnosis of coronary heart disease (CE-MARC): a prospective trial.Cardiovascular magnetic resonance of myocardial edema using a short inversion time inversion recovery (STIR) black-blood technique: diagnostic accuracy of visual and semi-quantitative assessment.Troponin-I concentration 72 h after myocardial infarction correlates with infarct size and presence of microvascular obstruction.Delayed enhancement imaging: standardised segmental assessment of myocardial viability in patients with ST-elevation myocardial infarction.Cardiovascular magnetic resonance of scar and ischemia burden early after acute ST elevation and non-ST elevation myocardial infarction.Inhibition of Dll4 signalling inhibits tumour growth by deregulating angiogenesis.A Nondestructive Method to Distinguish the Internal Constituent Architecture of the Intervertebral Discs Using 9.4 Tesla Magnetic Resonance Imaging.Comparative assessment of leflunomide and methotrexate for the treatment of rheumatoid arthritis, by dynamic enhanced magnetic resonance imaging.Coronary artery disease: assessment with a comprehensive MR imaging protocol--initial results.Assessment of non-ST-segment elevation acute coronary syndromes with cardiac magnetic resonance imaging.Fast MRI with turbo-FLASH sequences in aortoiliac disease.Assessment of myocardial perfusion-CMR in left main stem disease (LMS) in the CEMARC study.Color-encoded semiautomatic analysis of multi-slice first-pass magnetic resonance perfusion: comparison to tetrofosmin single photon emission computed tomography perfusion and X-ray angiography.Coronary artery disease: myocardial perfusion MR imaging with sensitivity encoding versus conventional angiography.
P50
Q26852691-8AC65648-C1BF-4AFE-9B28-B20FA3575984Q27660544-E9D3C33C-9568-457A-8EF0-202D17EC16E0Q30497816-BA5765B6-A6B4-42B2-8649-11799A99DE15Q33204483-C67281A5-BEAC-4142-8F7B-EE0CE8E22BD8Q33292067-47F9E1F5-7ED3-4C9A-9BAA-1241EEC414B4Q35575404-71E312A6-671D-4E7A-BBA5-1A29F532CE94Q35689753-2D86A320-9FA4-4A89-864B-B409A9161365Q35740419-129302CF-0994-49A3-BC88-4C954CB9D9B5Q35953519-B896BFC7-DAD4-47C4-82BB-74F04D327DDDQ36172904-EC23F406-3C91-4744-A46C-88E85A59F3D6Q36870329-2DBD3495-F2C9-4519-BF4E-6E0224AD155BQ36975290-3B11A95C-0601-419F-9D15-A8D64BFFF3B4Q40191484-FEAA81EB-DB81-4CBA-956C-BC3D97A468D4Q40302635-B225F722-F0A4-459F-8FE7-CBDA5EC1BBF9Q43882915-1602023F-CB0F-4255-B99E-FBDE793341B9Q44159279-2D4E2F17-E9C2-4390-8A76-B9EABDFF8E41Q45175884-D4E1B382-F8A2-433E-AF82-E968E8F55EFAQ45339858-AC332C10-D7D1-41C3-B831-E4A5DE725344Q45891564-ED6DF0E5-E890-4B65-B73A-E33255054628Q46376633-E9058473-0ED2-40B9-88DA-6F1940E3D6DDQ46461075-D42AF919-7E73-4E43-BE36-D61424705ED3
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
researcher
@en-gb
հետազոտող
@hy
name
John P Ridgway
@ast
John P Ridgway
@cy
John P Ridgway
@en
John P Ridgway
@en-gb
John P Ridgway
@es
John P Ridgway
@nl
John P Ridgway
@sl
type
label
John P Ridgway
@ast
John P Ridgway
@cy
John P Ridgway
@en
John P Ridgway
@en-gb
John P Ridgway
@es
John P Ridgway
@nl
John P Ridgway
@sl
altLabel
John Ridgway
@cy
John Ridgway
@en
John Ridgway
@en-gb
prefLabel
John P Ridgway
@ast
John P Ridgway
@cy
John P Ridgway
@en
John P Ridgway
@en-gb
John P Ridgway
@es
John P Ridgway
@nl
John P Ridgway
@sl